Charles Schwab Investment Management Inc Elevation Oncology, Inc. Transaction History
Charles Schwab Investment Management Inc
- $527 Billion
- Q4 2024
A detailed history of Charles Schwab Investment Management Inc transactions in Elevation Oncology, Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 124,181 shares of ELEV stock, worth $83,201. This represents 0.0% of its overall portfolio holdings.
Number of Shares
124,181
Previous 124,181
-0.0%
Holding current value
$83,201
Previous $74,000
2.7%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding ELEV
# of Institutions
68Shares Held
45.4MCall Options Held
700Put Options Held
27.6K-
Frazier Life Sciences Management, L.P. Menlo Park, CA5.99MShares$4.02 Million0.19% of portfolio
-
Tang Capital Management LLC San Diego, CA4.76MShares$3.19 Million0.24% of portfolio
-
Goldman Sachs Group Inc New York, NY3.99MShares$2.67 Million0.0% of portfolio
-
Farallon Capital Management LLC San Francisco, CA3.53MShares$2.36 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.07MShares$2.06 Million0.0% of portfolio
About Elevation Oncology, Inc.
- Ticker ELEV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 23,300,900
- Market Cap $15.6M
- Description
- Elevation Oncology, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapeutics for the treatment of cancer in genomically defined patient populations in the United States. The company's lead program is the seribantumab, an anti-HER3 monoclonal antibody that is in Phase II CRESTONE trial for the treatment of advanced sol...